These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1710676)

  • 1. [Immune response against BCG 65 kDa protein antigen in bladder cancer with BCG instillation therapy. Analyses carried out with the gene of this protein to develop a monoclonal antibody].
    Hara I; Sato N; Kikuchi K; Kamidono S
    Nihon Hinyokika Gakkai Zasshi; 1991 Jan; 82(1):24-32. PubMed ID: 1710676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacille Calmette-Guérin (BCG) in patients with superficial bladder cancer.
    Zlotta AR; Drowart A; Huygen K; De Bruyn J; Shekarsarai H; Decock M; Pirson M; Jurion F; Palfliet K; Denis O; Mascart F; Simon J; Schulman CC; Van Vooren JP
    Clin Exp Immunol; 1997 Jul; 109(1):157-65. PubMed ID: 9218839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of monoclonal antibodies reacting against mycobacterial 65 kDa heat shock protein by using recombinant truncated products.
    Hara I; Sato N; Matsuura A; Cho JM; Qi WM; Torigoe T; Shinnick TM; Kamidono S; Kikuchi K
    Microbiol Immunol; 1991; 35(11):995-1007. PubMed ID: 1685553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of recombinant antigens expressed in Escherichia coli K-12 to map B-cell and T-cell epitopes on the immunodominant 65-kilodalton protein of Mycobacterium bovis BCG.
    Thole JE; van Schooten WC; Keulen WJ; Hermans PW; Janson AA; de Vries RR; Kolk AH; van Embden JD
    Infect Immun; 1988 Jun; 56(6):1633-40. PubMed ID: 2453469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel B-cell epitope of restricted specificity on the hsp 65-kDa protein of Mycobacterium tuberculosis.
    Rambukkana A; Yong S; Das PK
    FEMS Microbiol Immunol; 1991 Feb; 3(1):39-45. PubMed ID: 1711877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guerin during intravesical treatment of superficial bladder cancer.
    Zlotta AR; Drowart A; Van Vooren JP; de Cock M; Pirson M; Palfliet K; Jurion F; Vanonckelen A; Simon J; Schulman CC; Huygen K
    J Urol; 1997 Feb; 157(2):492-8. PubMed ID: 8996341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genus-specific epitope on the 60-kilodalton Legionella heat shock protein recognized by a monoclonal antibody.
    Steinmetz I; Rheinheimer C; Hübner I; Bitter-Suermann D
    J Clin Microbiol; 1991 Feb; 29(2):346-54. PubMed ID: 1706730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of murine monoclonal antibodies specific for the 45/47 kDa antigen complex (APA) of Mycobacterium tuberculosis, M. bovis and BCG.
    Horn C; Pescher P; Romain F; Marchal G
    J Immunol Methods; 1996 Oct; 197(1-2):151-9. PubMed ID: 8890902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fate of bacillus Calmette-Guerin after intravesical instillation.
    Durek C; Richter E; Basteck A; Rüsch-Gerdes S; Gerdes J; Jocham D; Böhle A
    J Urol; 2001 May; 165(5):1765-8. PubMed ID: 11342972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravesical Bacillus Calmette-Guérin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of Bacillus Calmette-Guérin.
    Ratliff TL; Palmer JO; McGarr JA; Brown EJ
    Cancer Res; 1987 Apr; 47(7):1762-6. PubMed ID: 3545453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody responses to Bacillus Calmette-Guérin during immunotherapy in bladder cancer patients.
    Winters WD; Lamm DL
    Cancer Res; 1981 Jul; 41(7):2672-6. PubMed ID: 7018669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of cellular and humoral response against Tuberculin and antigen 85 complex during intravesical treatment with BCG of superficial bladder cancer.
    Zlotta A; Drowart A; van Vooren JP; Simon J; Schulman CC; Huygen K
    Acta Urol Belg; 1994 Sep; 62(3):63-8. PubMed ID: 7976857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of recombinant Bacille Calmette-Guérin secreting interleukin-15-Ag85B fusion protein against bladder cancer.
    Takeuchi A; Eto M; Tatsugami K; Shiota M; Yamada H; Kamiryo Y; Dejima T; Kashiwagi E; Kiyoshima K; Inokuchi J; Takahashi R; Yokomizo A; Ohara N; Yoshikai Y
    Int Immunopharmacol; 2016 Jun; 35():327-331. PubMed ID: 27093372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of interleukin 2 in the urine of patients with superficial bladder tumors after treatment with intravesical BCG.
    Haaff EO; Catalona WJ; Ratliff TL
    J Urol; 1986 Oct; 136(4):970-4. PubMed ID: 3489840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of antigens recognized by new monoclonal antibodies raised against culture filtrate proteins of Mycobacterium bovis bacillus Calmette-Guérin.
    Freer G; Florio W; Dalla Casa B; Castagna B; Maisetta G; Batoni G; Corsini V; Senesi S; Campa M
    FEMS Immunol Med Microbiol; 1998 Feb; 20(2):129-38. PubMed ID: 9544780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCG-induced interleukin-6 upregulation and BCG internalization in well and poorly differentiated human bladder cancer cell lines.
    Bevers RF; de Boer EC; Kurth KH; Schamhart DH
    Eur Cytokine Netw; 1998 Jun; 9(2):181-6. PubMed ID: 9681394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical instillation therapy with bacillus Calmette-Guérin for superficial bladder cancer: study of the mechanism of bacillus Calmette-Guérin immunotherapy.
    Shintani Y; Sawada Y; Inagaki T; Kohjimoto Y; Uekado Y; Shinka T
    Int J Urol; 2007 Feb; 14(2):140-6. PubMed ID: 17302571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble urinary CD14 after intravesical bacille Calmette-Guérin immunotherapy for carcinoma in situ.
    Jackson AM; Lien E; Alexandroff AB; Prescott S; Espevik T; James K; Selby PJ; Sundan A
    Br J Urol; 1997 Nov; 80(5):766-71. PubMed ID: 9393300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to 65 kDa and 70 kDa heat shock proteins in rheumatoid arthritis and systemic lupus erythematosus.
    Panchapakesan J; Daglis M; Gatenby P
    Immunol Cell Biol; 1992 Oct; 70 ( Pt 5)():295-300. PubMed ID: 1478694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope mapping of Escherichia coli cell division protein FtsZ with monoclonal antibodies.
    Voskuil JL; Westerbeek CA; Wu C; Kolk AH; Nanninga N
    J Bacteriol; 1994 Apr; 176(7):1886-93. PubMed ID: 7511580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.